Molekularpathologie kolorektaler Karzinome-Reference-Cited by-同舟云学术

Molekularpathologie kolorektaler Karzinome

Published:2023-06-05 Issue:5 Volume:44 Page:279-286
ISSN:2731-7188
Container-title:Die Pathologie
language:de
Short-container-title:Pathologie

Author:

Woischke Christine,Michl Marlies,Neumann Jens

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00292-023-01201-9.pdf

Reference63 articles.

1. SCC (2013) COSMIC (Catalogue of Somatic Mutations in Cancer)

2. Adelstein BA, Dobbins TA, Harris CA et al (2011) A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancer. Eur J Cancer 47:1343–1354

3. Ahcene Djaballah S, Daniel F, Milani A et al (2022) HER2 in colorectal cancer: the long and winding road from negative predictive factor to positive actionable target. Am Soc Clin Oncol Educ Book 42:1–14

4. Ahluwalia P, Kolhe R, Gahlay GK (2021) The clinical relevance of gene expression based prognostic signatures in colorectal cancer. Biochim Biophys Acta Rev Cancer 1875:188513

5. Allar BG, Messaris E, Poylin VY et al (2022) Oncotype DX testing does not affect clinical practice in stage IIa colon cancer. Med Oncol 39:59

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five decades of colorectal cancer pathology: The World and China;Chinese Science Bulletin;2024-05-01

2. Kolonpolypen – Nomenklatur, Histologie und Molekularpathologie;Die Gastroenterologie;2024-03-28